Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,481.60
(
0.35%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
108.46
(
1.30%
)
Bitcoin
68,545.02
(
-0.45%
)
News Focus
News Focus
Post# of 405171
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 70
Posts 8960
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: loanranger post# 393849

Monday, 10/03/2022 9:42:38 PM

Monday, October 03, 2022 9:42:38 PM

Post# of 405171
If B the inhaler is so close to market then there should be available $ to accelerate K.

I conclude B isn’t even close to being monetized.

"We hold FTD, RPDD, and ODD for Rett." Coupled with clinically meaningful & statistically significant data will move the FDA to AA...What's the point in issuing these designations if clinically meaningful and stat sig data isn't enough? Approval in 3 mo

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote